Although it was first reported >40 years ago that mRNAs, like DNA, also contain methylated bases, specifically N6-methyadnosine, or m6A [1], its reversibility [2] and transcriptome-wide mapping of m6A were only reported recently [3, 4] . Using anti-m6A antibodybased immunoprecipitation followed by deep sequencing (m6A-Seq), >12 000 potential m6A sites on mRNAs encoded by ∼7000 genes have been identified in mammalian cells [3, 4] . Interestingly, the nonrandom location of m6A marks on mRNAs (e.g., enrichment in 3'untranslated regions (UTRs) and near the stop codon) suggests that this RNA mark may have a role in post-transcriptional regulation. Indeed, further studies on the m6A writers (those that can add the methyl group to the N6 position of adenosine, e.g., METTL3, METTL4, and WTAP) and erasers (those that can remove the methyl group, e.g., FTO and ALKBH5), as well as m6A readers (those that bind specifically m6A marks and trigger downstream cellular events, e.g., YTHDF and YTHDC families), have suggested that these m6A marks can affect mRNA splicing, translational status, and stability [5] . However, the effects were observed mainly in cultured cells in vitro, and data from animal models lacking the m6A writer, eraser, and reader proteins just started emerging [6, 7] .
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A very recent report [7] by Chuan He's lab has shown that inactivation of ythdf2 in zebrafish, a m6A reader protein abundantly expressed in oocytes and throughout early embryonic development, leads to a significant delay in timely clearance of a significant proportion of the maternal transcripts during maternal-to-zygotic transition (MZT), and consequently a block in late G2 to early M phases of the cell cycle in one-cell embryos. By profiling mRNAs using mRNASeq and mapping m6A sites using m6A-CLIP-Seq, m6A peaks were found in >40% of gene transcripts (4600 out of 11631) and >36% of the maternal transcripts appeared to contain m6A marks during MZT in wild-type one-cell embryos [7] . Intriguingly, in one-cell embryos derived from ythdf2-dificicent eggs, the m6A abundance increased by >50%, and ∼60% of the upregulated, m6A-containing transcripts were maternal transcripts. Similar results were obtained when a translation-blocking morpholino specific for zebrafish ythdf2 was used to block YTHDF2 production in oocytes [7] . The fact that a lack of YTHDF2 can cause an accumulation of m6A-containing maternal transcripts suggests that m6A marks normally can trigger maternal transcript degradation during MZT. Indeed, a green fluorescent protein (GFP)-based reporter assay demonstrated that the m6A-containing reporter mRNAs degraded much faster that those without the m6A mark during MTZ in WT one-cell embryos. In contrast, in the embryos derived from ythdf2-dificicent eggs, the clearance of m6A-containing reporter mRNAs was drastically slowed down during MZT, as compared to the unmethylated reporter mRNAs [7] . Taken together, this in vivo study has demonstrated a novel role of m6A in the control of maternal transcript turnover during MZT, i.e., YTHDF2-dependent clearance of m6A-marked maternal transcripts (Figure 1) . However, it is noteworthy that ∼30% of progeny derived from maternal ythdf2 −/− mating pairs can survive and develop to adulthood despite the absence of both maternal and zygotic ythdf2. This may be explained by the existence of numerous alternative pathways for selective degradation of maternal transcripts during MZT [8] [9] [10] . Nevertheless, m6A marking of mRNAs appears to be a novel mechanism underlying post-transcriptional control of mRNA fate, which may be a universal mechanism utilized by other cell types. Therefore, epitranscriptomic analyses (e.g., HPLC-based m6A quantification, and m6A mapping using m6A-CLIP-Seq), in addition to transcriptomic analyses, will become critical for studying the post-transcriptional regulation of gene expression in future studies. Wild-type (WT) eggs contain a large number of m6A-marked maternal transcripts, which will degrade in a YTHDF2-dependent manner during MZT. The ythdf2 knockout (KO) eggs lack YTHDF2 and thus, m6A-marked maternal transcripts fail to be removed and the persistent maternal transcripts disrupt normal MZT, leading to a complete block in late G2 and early M phase of the cell cycle in one-cell embryos.
